1. Home
  2. COOK vs MXCT Comparison

COOK vs MXCT Comparison

Compare COOK & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Traeger Inc.

COOK

Traeger Inc.

HOLD

Current Price

$28.17

Market Cap

83.7M

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$0.75

Market Cap

86.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COOK
MXCT
Founded
1985
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.7M
86.5M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
COOK
MXCT
Price
$28.17
$0.75
Analyst Decision
Hold
Buy
Analyst Count
5
4
Target Price
$58.00
$7.50
AVG Volume (30 Days)
535.0K
976.9K
Earning Date
03-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$559,520,000.00
$38,627,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.50
$9.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$0.64
52 Week High
$35.56
$3.17

Technical Indicators

Market Signals
Indicator
COOK
MXCT
Relative Strength Index (RSI) 79.73 39.00
Support Level $0.98 $0.75
Resistance Level N/A $0.87
Average True Range (ATR) 1.45 0.06
MACD 3.40 0.01
Stochastic Oscillator 77.71 13.19

Price Performance

Historical Comparison
COOK
MXCT

About COOK Traeger Inc.

Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

Share on Social Networks: